VIDEO: Pegcetacoplan well tolerated in DERBY, OAKS trials

Issue: November 10, 2021

ByCharles C. Wykoff, MD, PhD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this video from the Retina Society meeting, Charles Wykoff, MD, PhD, discusses results from the DERBY and OAKS trials investigating pegcetacoplan in patients with geographic atrophy secondary to age-related macular degeneration.

Published by:

Sources/Disclosures

Collapse

Source: Charles Wykoff, MD, PhD

Read more about

pegcetacoplan

geographic atrophy

wet age-related macular degeneration

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment